Following the announcement by the WHO of a pandemic on 11 March 2020, routine gastrointestinal endoscopic procedures were suspended internationally with only life-threatening emergencies and severe conditions being performed. We, therefore, read with interest the article by Rutter et al on the impact of COVID-19 on endoscopy services and cancer detection (1). One patient category not fully addressed in this publication is the subgroup of patients who underwent endoscopic retrograde cholangiopancreatography (ERCP) with biliary stent placement prior to introduction of restricted activity. Under normal circumstances, many of these patients would have undergone endoprosthesis replacement or revision prior to potential endoscopic activity later in 2020. Guidance statements from international professional bodies are inconsistent with the Asian Pacific Society for Digestive Endoscopy (APSDE)-COVID statement, this group has …

中文翻译：

---

大流行期间应优先移除导管内胆管支架

在世界卫生组织于 2020 年 3 月 11 日宣布大流行之后，国际上暂停了常规的胃肠道内窥镜检查程序，只进行了危及生命的紧急情况和严重的情况。因此，我们感兴趣地阅读了 Rutter 等人关于 COVID-19 对内窥镜检查服务和癌症检测的影响的文章 (1)。本出版物中没有完全解决的一类患者是在引入限制性活动之前接受内镜逆行胰胆管造影 (ERCP) 并放置胆管支架的患者亚组。在正常情况下，这些患者中的许多人会在 2020 年晚些时候进行潜在的内窥镜检查活动之前进行内置假体更换或翻修。